CFDB - Cystic Fibrosis DataBase

Welcome in CFDB (Cystic Fibrosis DataBase)!

This is a web-based, free access tool for health care professionals, researchers and students to evaluate in real time what are the current evidences about clinical efficacy of interventions in CF.

You'll find more than 1,500 studies divided in 8 sections, including Cochrane reviews, Cochrane protocols, DARE, HTA and Economic reviews, published RCT, published non-RCT, congress abstracts and ongoing trials.

Objective of CFDB (Cystic Fibrosis DataBase)

CFDB is a database and was ideated to classify clinical studies to get answers to specific questions:

  • which interventions are effective, in which groups of CF patients and for which outcomes?
  • to what extent do the results of the literature allow to make decisions for specific clinical issues? What issues need to be studied further?

This tool may help clinicians, researchers, students to have a faster updated view of clinical research in CF by using queries on the main topics in CF care. It could also be helpful to anyone going to design new studies, as it provides a concise description of what is currently known and what issues, on the contrast, need additional research.

Latest articles

Vitamin E supplementation in people with cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2020
  • Okebukola Peter O

Pancreatic enzyme replacement therapy for people with cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2020
  • Somaraju Usha Rani

Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2020
  • Hurley Matthew N

Vitamin K supplementation for cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2020
  • Jagannath Vanitha A

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis

Cochrane Database of Systematic Reviews - Cochrane Review

Details
  • 2020
  • Waters Valerie

Aerosolized lancovutide in adolescents (≥12 years) and adults with cystic fibrosis - a randomized trial.

primary studies published RCT

Details
  • 2020
  • Eber E

Improved outcomes in cystic fibrosis using modified Re-Education of Airway Clearance Technique (REACT) programme.

primary studies published, non RCT

Details
  • 2020
  • Reamer C